Stefano Romeo

22.9k citations
202 papers · 11.9k indexed · 5 hit papers · h-index 53

Impact in

Papers in

Stefano Romeo

197 papers receiving 11.7k citations

Hit Papers

The first MASH drug therapy on the horizon: Current perspectives of resmetirom 2024 · 82 citations
82200820262014202050010001.5k2.0k

Peers

Stefano Romeo
Comparison fields: 5 of 147
  • Endocrinology, Diabetes and Metabolism 4.5k
  • Hepatology 2.1k
  • Epidemiology 7.3k
  • Biochemistry 928
  • Cell Biology 1.5k
Replace Nicolas Musi with:
Nicolas Musi United States
Franco Folli Italy
Philippe Gual France
Douglas E. Befroy United States
Ángela M. Valverde Spain
Andrea L. Hevener United States
Youfei Guan China
Cem Z. Görgün United States
Peter A. Crawford United States
Jongsoon Lee United States
Stefano Romeo relative to Nicolas Musi United States Nicolas Musi's profile →
Citations per field
00.5×6.9×
Nicolas Musi · 1×
Citations per year

Countries citing papers authored by Stefano Romeo

Since Specialization
Citations

This map shows the geographic impact of Stefano Romeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Romeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Romeo more than expected).

Fields of papers citing papers by Stefano Romeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Romeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Romeo. The network helps show where Stefano Romeo may publish in the future.

Co-authors

The 25 scholars most cited alongside Stefano Romeo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefano Romeo Line = papers co-authored together Stefano Romeo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
The first MASH drug therapy on the horizon: Current perspectives of resmetirom
Hit paper breakdown →
202482
2 20249
3 202434
4 202419
5 20224
6 202222
7 202224
8 202123
9 202117
10 202153
11 202112
12 202029
13 202050
14 20207
15 202032
16 202097
17 201998
18 201910
19 201945
20
Long-Term Effect of Bariatric Surgery on Liver Enzymes in the Swedish Obese Subjects (SOS) Study
20133

About Stefano Romeo

Stefano Romeo is a scholar working on Endocrinology, Diabetes and Metabolism, Hepatology, Biochemistry, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 202 papers that have together received 11.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (96 papers), Diet, Metabolism, and Disease (42 papers), Lipid metabolism and disorders (27 papers), Lipid metabolism and biosynthesis (23 papers), Endoplasmic Reticulum Stress and Disease (22 papers), Diet and metabolism studies (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Pancreatic function and diabetes (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.5k citations), Hepatology (2.1k citations), Epidemiology (7.3k citations), Biochemistry (928 citations) and Cell Biology (1.5k citations). Stefano Romeo has collaborated with scholars based in Italy, Sweden and United States. Frequent co-authors include Luca Valenti, Helen H. Hobbs, Jonathan C. Cohen, Eric Boerwinkle, L Pennacchio, Julia Kozlitina, Chao Xing, Alexander Pertsemlidis, David Cox and Mohammed Eslam. Their work appears in journals such as Liver International, Journal of Hepatology, Nutrients, Journal of Translational Medicine and Nutrition Metabolism and Cardiovascular Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026